{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:53:32Z","timestamp":1774623212573,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:sec><jats:title>Background and objective<\/jats:title><jats:p>Bisphosphonate\u2010associated osteonecrosis of the jaw (BONJ) is an emerging oral complication that occurs most commonly in the setting of high\u2010dose bisphosphonate therapy for cancer. The purpose of this study was to estimate the health care\u2013related costs associated with a diagnosis of BONJ in patients with cancer evaluated and managed at one tertiary oral medicine practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a retrospective electronic medical record review of cancer patients with BONJ. All health care\u2013related resources were abstracted using a structured chart abstraction tool; data captured included medications, imaging studies, laboratory investigations, procedures, and visits. Standardized references were used to assign costs in 2010 US dollars.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ninety\u2010two cancer patients with BONJ were identified who were followed for a median of 12\u00a0months. The median cost of a case of BONJ was $1667 (interquartile range from $976 to $3350). Medication costs comprised the majority (42%) of the total costs, followed by procedural interventions (22%), clinic visits (19.5%), and imaging studies (13.8%). Patient factors associated with higher median costs included a greater number of involved oral quadrants and more advanced BONJ stage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There are considerable costs associated with the diagnosis and management of BONJ in patients with cancer, with medications accounting for nearly half of resource expenditures.<\/jats:p><\/jats:sec>","DOI":"10.1111\/odi.12080","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T04:58:39Z","timestamp":1359349119000},"page":"94-99","source":"Crossref","is-referenced-by-count":12,"title":["Resource utilization in cancer patients with bisphosphonate\u2010associated osteonecrosis of the jaw"],"prefix":"10.1111","volume":"20","author":[{"given":"MS","family":"Najm","sequence":"first","affiliation":[{"name":"Division of Oral Medicine College of Dentistry Al\u2010Mustansiriya University Baghdad Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DH","family":"Solomon","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology Division of Rheumatology Brigham and Women's Hospital Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u2010B","family":"Woo","sequence":"additional","affiliation":[{"name":"Division of Oral Medicine and Dentistry Brigham and Women's Hospital Boston MA USA"},{"name":"Department of Oral Medicine Infection and Immunity Harvard School of Dental Medicine Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NS","family":"Treister","sequence":"additional","affiliation":[{"name":"Division of Oral Medicine and Dentistry Brigham and Women's Hospital Boston MA USA"},{"name":"Department of Oral Medicine Infection and Immunity Harvard School of Dental Medicine Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,2,19]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"https:\/\/ocm.ama-assn.org CodeManager (Metropolitan Boston)."},{"key":"e_1_2_8_3_1","volume-title":"The Red Book of Medicines","year":"2008"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2008.09.021"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2005.08.001"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.8670"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1259\/dmfr\/27458726"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2008.0110"},{"key":"e_1_2_8_9_1","first-page":"1391","article-title":"Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw","volume":"35","author":"Khan AA","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_8_10_1","first-page":"417","article-title":"A review of bisphosphonate\u2010associated osteonecrosis of the jaws and its management","volume":"73","author":"Lam DK","year":"2007","journal-title":"J Can Dent Assoc"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.03.050"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2005.07.010"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70726-4"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0183"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cden.2007.09.002"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/jop.2006.2.1.7"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.01.009"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.04.051"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2008.01494.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2008.10.009"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2006.12.005"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2009.11.014"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2008.12.030"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fodi.12080","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/odi.12080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T09:25:08Z","timestamp":1696152308000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/odi.12080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,19]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1111\/odi.12080"],"URL":"https:\/\/doi.org\/10.1111\/odi.12080","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,19]]}}}